Roblox Corporation: BMO cuts target price to $43 from $45
RBLX•BMO cut its target price for Roblox Corporation to $43 from $45.
Related News
Immunome announces EMA validation of marketing authorization application for varegacestat to treat adults with desmoid tumors
IMNM•
Allarity Therapeutics secures first lab services contract with European biotech company
ALLR•
U.S. stocks on the move: Chevron, Regeneron, ExxonMobil
CVX•
American Tower Corporation: Truist Securities raises target price to $210 from $207
AMT•
Entegris target price raised to $199 from $190 by Truist Securities
ENTG•